XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact
The Pharma Data
JANUARY 27, 2021
CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (“ XPhyto ” or the “ Company “) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. In-house commercial manufacturing capacity, as set out above, is expected to maximize profitability of the biosensor commercialization.
52 
Let's personalize your content